Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+0.37%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$15.2B
AUM Growth
+$365M
Cap. Flow
+$16.5M
Cap. Flow %
0.11%
Top 10 Hldgs %
31.7%
Holding
1,372
New
93
Increased
870
Reduced
195
Closed
27

Sector Composition

1 Real Estate 55.89%
2 Technology 9.18%
3 Communication Services 4.61%
4 Consumer Discretionary 4.25%
5 Financials 3.6%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EDU icon
1101
New Oriental
EDU
$7.98B
$11K ﹤0.01%
520
-7,188
-93% -$152K
INSM icon
1102
Insmed
INSM
$30.7B
$11K ﹤0.01%
395
+191
+94% +$5.32K
NKTR icon
1103
Nektar Therapeutics
NKTR
$764M
$11K ﹤0.01%
42
+18
+75% +$4.71K
PRTA icon
1104
Prothena Corp
PRTA
$460M
$11K ﹤0.01%
154
+66
+75% +$4.71K
SWTX
1105
DELISTED
SpringWorks Therapeutics
SWTX
$11K ﹤0.01%
168
+76
+83% +$4.98K
VCYT icon
1106
Veracyte
VCYT
$2.55B
$11K ﹤0.01%
243
+110
+83% +$4.98K
RETA
1107
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$11K ﹤0.01%
108
+46
+74% +$4.69K
TPTX
1108
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$11K ﹤0.01%
169
+74
+78% +$4.82K
NFH
1109
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
$11K ﹤0.01%
+1,013
New +$11K
ALXO icon
1110
ALX Oncology
ALXO
$65.3M
$10K ﹤0.01%
138
+59
+75% +$4.28K
APLS icon
1111
Apellis Pharmaceuticals
APLS
$3.55B
$10K ﹤0.01%
298
+139
+87% +$4.66K
AUPH icon
1112
Aurinia Pharmaceuticals
AUPH
$1.63B
$10K ﹤0.01%
440
+202
+85% +$4.59K
CYTK icon
1113
Cytokinetics
CYTK
$6.34B
$10K ﹤0.01%
286
+153
+115% +$5.35K
EDIT icon
1114
Editas Medicine
EDIT
$248M
$10K ﹤0.01%
234
+101
+76% +$4.32K
IMAB
1115
I-MAB
IMAB
$358M
$10K ﹤0.01%
144
+81
+129% +$5.63K
RLAY icon
1116
Relay Therapeutics
RLAY
$710M
$10K ﹤0.01%
317
+148
+88% +$4.67K
ZNTL icon
1117
Zentalis Pharmaceuticals
ZNTL
$126M
$10K ﹤0.01%
154
+78
+103% +$5.07K
ITCI
1118
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$10K ﹤0.01%
279
+128
+85% +$4.59K
PTCT icon
1119
PTC Therapeutics
PTCT
$4.55B
$9K ﹤0.01%
242
+103
+74% +$3.83K
QNCX icon
1120
Quince Therapeutics
QNCX
$86.5M
$9K ﹤0.01%
102
+47
+85% +$4.15K
ACAD icon
1121
Acadia Pharmaceuticals
ACAD
$4.26B
$9K ﹤0.01%
550
+233
+74% +$3.81K
AGIO icon
1122
Agios Pharmaceuticals
AGIO
$2.09B
$9K ﹤0.01%
202
+80
+66% +$3.56K
BCRX icon
1123
BioCryst Pharmaceuticals
BCRX
$1.74B
$9K ﹤0.01%
613
+281
+85% +$4.13K
FOLD icon
1124
Amicus Therapeutics
FOLD
$2.46B
$9K ﹤0.01%
913
+423
+86% +$4.17K
MYGN icon
1125
Myriad Genetics
MYGN
$615M
$9K ﹤0.01%
267
+126
+89% +$4.25K